Evaluation of Kaletra Therapy Over the Long-term.
Phase of Trial: Phase IV
Latest Information Update: 09 Aug 2011
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 10 Jun 2017 Biomarkers information updated
- 30 Jun 2011 Actual end date (1 Jun 2010) added as reported by ClinicalTrials.gov.
- 30 Jun 2011 Secondary endpoint identified as CD4+ cell count and viral- oad as reported by ClinicalTrials.gov.